Brain Scientific

Brain Scientific OCF/Debt

The Operating Cash Flow to Debt Ratio of Brain Scientific (BRSF) as of Oct 31, 2026 is -214.44 %. In the previous year, Operating Cash Flow to Debt Ratio was -56.12 % — a change of 282.12% (lower).

OCF/Debt

-214.44 %

YoY

282.12%

Last updated:

Operating Cash Flow to Debt Ratio of Brain Scientific is 2022 -214.44 % . Operating Cash Flow to Debt Ratio of Brain Scientific was 2021 -56.12 % . It decreases by 282.12% lower compared to the previous year.

The Brain Scientific OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2016
-75.00 USD
Jan 1, 2017
-85.71 USD
Jan 1, 2018
-2,220.00 USD
Jan 1, 2019
-96.59 USD
Jan 1, 2020
-73.13 USD
Jan 1, 2021
-56.12 USD
Jan 1, 2022
-214.44 USD
The Brain Scientific OCF/Debt history
YEAROCF/DebtYoY
-214.44 %+282.12%
-56.12 %-23.26%
-73.13 %-24.29%
-96.59 %-95.65%
-2,220.00 %+2,490.00%
-85.71 %+14.29%
-75.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Brain Scientific Stock analysis

What does Brain Scientific do? Brain Scientific Inc. generates revenue through its subsidiaries Memory MD, Inc. and Piezo Motion Corp., which offer complementary medical device and software solutions. Memory MD, Inc. focuses on neurology products including the NeuroCap, a disposable EEG cap with integrated electrodes designed to improve conventional EEG systems, and NeuroEEG, a wireless EEG system connecting to computers. Piezo Motion Corp. develops small piezoelectric motors and micro dosing pumps for medical devices and other industries, with twelve commercial motor platforms available. The company's products are sold to healthcare providers and medical device manufacturers seeking advanced neurology and motion technologies. The NeuroCap and NeuroEEG systems target neurology clinics and hospitals requiring efficient EEG data acquisition and analysis, while Piezo Motion Corp.'s motors serve medical device makers and industrial clients needing precise motion control. Memory MD, Inc.'s products address the neurology market segment, and Piezo Motion Corp. serves both medical device and non-medical device industries with its motion products. The company's centralized platform integrates EEG data acquisition with cloud-based telehealth services, enhancing its value proposition for healthcare providers. Brain Scientific Inc. monetizes its subsidiary products by selling medical devices, software, and motion components directly to healthcare institutions and manufacturers. Memory MD, Inc. provides neurology-specific solutions like the NeuroCap and NeuroEEG, while Piezo Motion Corp. offers piezoelectric motors and micro dosing pumps for diverse applications. The company's revenue streams are derived from these two distinct product lines, each serving specific market segments within the medical technology sector. Brain Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brain Scientific stock

Operating Cash Flow to Debt Ratio of Brain Scientific is -214.44 % in 2022.

Operating Cash Flow to Debt Ratio of Brain Scientific changed from -56.12 % to -214.44 %, representing a 282.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Brain Scientific since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Brain Scientific with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Brain Scientific

All Key Metrics — Brain Scientific